What are the key differences between NRAS and KRAS mutations in cancer, and how do they impact treatment options and patient outcomes?

NRAS and KRAS mutations are both genetic alterations commonly found in cancer cells. The key difference between them is their location within the cell signaling pathway. NRAS mutations occur upstream, while KRAS mutations occur downstream. These differences can impact how cancer cells respond to certain treatments.

In terms of treatment options, patients with NRAS mutations may not respond as well to certain targeted therapies compared to those with KRAS mutations. This can affect the effectiveness of treatment and ultimately impact patient outcomes. Understanding the specific mutation present in a patient's cancer can help guide treatment decisions and improve the chances of a successful outcome.